4338-48-1

4338-48-1 structure

Name: N6-(2-Hydroxyethyl)adenosine
Chemical Name: (2R,3R,4S,5R)-2-(6-((2-Hydroxyethyl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
CAS Number: 4338-48-1
Molecular Formula: C₁₂H₁₇N₅O₅
Molecular Weight: 311.29
Catalog: Signaling Pathways Cell Cycle/DNA Damage Nucleoside Antimetabolite/Analog
Create Date: 2018-06-16 17:23:33
Modify Date: 2024-01-09 10:14:23
N6-(2-Hydroxyethyl)adenosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

Name	(2R,3R,4S,5R)-2-(6-((2-Hydroxyethyl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
Synonyms	(2R,3R,4S,5R)-2-[6-(2-hydroxyethylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

Description	N6-(2-Hydroxyethyl)adenosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Cell Cycle/DNA Damage >> Nucleoside Antimetabolite/Analog
References	[1]. Man S, et al. Potential and promising anticancer drugs from adenosine and its analogs. Drug Discov Today. 2021 Jun;26(6):1490-1500. [2]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.

Hazard Codes	Xi

96655-92-4

~94%

4338-48-1

Literature: Fujii, Tozo; Saito, Tohru; Terahara, Norihiko Chemical & Pharmaceutical Bulletin, 1986 , vol. 34, # 3 p. 1094 - 1107

96655-92-4

~50%

33962-62-8

4338-48-1

Literature: Fujii, Tozo; Saito, Tohru; Terahara, Norihiko Chemical & Pharmaceutical Bulletin, 1986 , vol. 34, # 3 p. 1094 - 1107